Contact
Please use this form to send email to PR contact of this press release:
KRBP CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending
TO: